RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction
RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction
Not yet recruiting · NCT07166380 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-30 | NCT07166380 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd | 2 |
| Neurodawn Pharmaceutical Co., Ltd. | 10 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital | Beijing | China | 62 |